Rajendra Apte and colleagues from the Washington University School of Medicine used a mouse model of choroidal neovascularization—new vessel formation, (CNV) —which is an important part of AMD, to show that preventing macrophage entry into the eye encouraged new vessel formation, whereas direct injection of macrophages significantly inhibited this process.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 50 y of age in at least three continents. CNV is the process by which abnormal blood vessels develop underneath the retina. CNV develops in 10% of patients with AMD but accounts for up to 90% of the blindness from AMD. This study suggests that regulators of macrophages may be a possible therapeutic target in AMD.
Citation: Apte RS, Richter J, Herndon J, Ferguson TA (2006) Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 3(8): e310.
Andrew Hyde | Source: alphagalileo
Further information: www.plosmedicine.org/
More articles from
Health and Medicine:
Leeds project aims to boost parents’ confidence in MMR choices as measles rates rise
25.07.2008 | University of Leeds
Allergic rhinitis diagnosis and treatment: new guidelines for primary care professionals
24.07.2008 | GA²LEN Dissemination - Interel
Object intermediate between normal supernovae and gamma-ray bursts found
25.07.2008 | Physics and Astronomy
Leeds project aims to boost parents’ confidence in MMR choices as measles rates rise
25.07.2008 | Health and Medicine
COROT’s new find orbits Sun-like star
25.07.2008 | Physics and Astronomy